BioCentury
ARTICLE | Clinical News

Zinbryta daclizumab regulatory update

July 18, 2016 7:00 AM UTC

The European Commission approved Zinbryta daclizumab from Biogen to treat relapsing forms of multiple sclerosis (MS). In May, FDA approved a BLA for the once-monthly humanized IgG1 mAb against IL-2 r...